Babs Posted May 20, 2021 Share Posted May 20, 2021 Hi all, So I’ve had a recurrence and I need to make a decision of whether to do a clinical trial or standard chemo/immuno. The clinical trial is a new drug Datopotamab Deruxtecan combined with Keytruda and possibly Carboplatin. It’s a phase 1 trial through the Mayo Clinic. The standard treatment would be Taxotere and Cymraza which I believe is a pretty tough combo. I had a video visit with my Onc here yesterday and she brought up a good point that the standard treatment would always be available but not this clinical trial. If I’m going to do this clinical trial it’s now or I can’t as doing the standard treatment would make me ineligible. It would mean a long battery of tests including another biopsy and several trips down to the Mayo. https://clinicaltrials.gov/ct2/show/NCT04526691 I’m not sure what questions I should be asking about the trial. Does anybody have any input out there? I’m very confused of which way to go. Thanks, Babs ColleenRae, TJM and DMiller 2 1 Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.